Dr. Josef Coresh

Who Dr. Josef Coresh is

Josef Coresh, MD, PhD is the Founding Director of the Optimal Aging Institute at NYU Grossman School of Medicine and a Professor of Population Health and Medicine, holding the Terry and Mel Karmazin endowed chair. He is an epidemiologist and internationally recognised expert in aging and vascular disease epidemiology of the brain, heart, and kidney, with over 1,000 published scientific papers cited more than 420,000 times on Google Scholar. He co-led the ACHIEVE randomised controlled trial, published in The Lancet in 2023, which provided the most rigorous evidence that hearing intervention slows cognitive decline by 48% over three years in older adults at heightened dementia risk. In January 2025 he was senior author on a Nature Medicine study estimating the lifetime dementia risk after age 55 at 42%—more than twice previous estimates—and projecting approximately one million new US dementia cases annually by 2060. He has been quoted in UK and international press coverage on dementia prevention, vascular risk factors, and the preventability of age-related cognitive decline. He received the top scientific and patient impact awards of the US National Kidney Foundation (Eknoyan and Hume Awards) and the American Society of Nephrology (Belding Scribner Award).

References for this biography

1. 1.Josef Coresh, MD, PhD – NYU Grossman School of Medicine faculty page — Current role, title, institute, and research interests at NYU Langone
2. 2.Dr. Josef Coresh on Living a Longer, Healthier, Happier Life – NYU Langone News — Founding director role, 1,000+ papers, January 2025 Nature Medicine dementia study, advocacy positions on aging
3. 3.Lifetime risk and projected burden of dementia – Nature Medicine (January 2025) — 42% lifetime dementia risk finding; projection to 1 million annual cases by 2060; Coresh as corresponding author
4. 4.ACHIEVE Study Results Published, Presented – Johns Hopkins Cochlear Center — Co-PI role on ACHIEVE trial; 48% slowing of cognitive decline finding published in The Lancet, July 2023
5. 5.Josef Coresh – Johns Hopkins Bloomberg School of Public Health faculty page — Awards: NKF Eknoyan (2010), Hume (2015), ASN Scribner (2020); Highly Cited Researcher status from 2014
6. 6.Three simple changes in middle age could give you 13 more years without dementia – BBC Science Focus Magazine — Confirms Coresh quoted in UK press (BBC Science Focus) as senior investigator on dementia prevention research
7. 7.Dementia Risk and Prevention – Harvard T.H. Chan School of Public Health Epidemiology Seminar Series — Awards confirmation (Eknoyan, Hume, Scribner); ARIC NCS co-lead; citation count >300,000

Notable achievements

• Co-led the ACHIEVE randomised controlled trial (published in The Lancet, July 2023), which found hearing intervention slowed cognitive decline by 48% over three years in older adults at high dementia risk. Source ↗
• Senior author of a January 2025 Nature Medicine study estimating the US lifetime dementia risk from age 55–95 at 42%, more than twice prior estimates, projecting ~1 million annual new cases by 2060. Source ↗
• Received the National Kidney Foundation's Garabed Eknoyan Award (2010) and David M. Hume Memorial Award (2015), and the American Society of Nephrology Belding Scribner Award (2020). Source ↗
• Recognised since 2014 each year as among the top 1% of researchers globally in Clinical Medicine by article citations (Thomson Reuters/Clarivate Highly Cited Researchers). Source ↗

What Dr. Josef Coresh has said

• “Be aggressive. Even delaying those risky conditions has a huge payoff.”

  senior author, NYU Langone Health · Dementia · 29 Sept 2026 · Looking to lower your risk of Alzheimer’s? It doesn’t involve a blood test ↗

• “We found if you had more risk factors, you had an elevated risk of both dementia and mortality”

  director of the Optimal Aging Institute at NYU Langone Health · Dementia · 12 Aug 2026 · How 3 health factors can help delay dementia for up to 13 years ↗

• “need to actively avert these factors in midlife as a strategy for preserving brain health for more than a decade”

  Director of the Optimal Ageing Institute at NYU Langone · Dementia · 12 Aug 2026 · Three middle-age health rules could bring an extra 13 years without dementia, experts say ↗

• “We thought focusing on time gained may help get across the benefits of averting dementia risks.”

  at New York University · Dementia · 10 Aug 2026 · Three factors in midlife can delay the onset of dementia by 13 years ↗

Where Dr. Josef Coresh has been quoted

1. Targeting 3 Risk Factors May Let You Live 13 Years Longer Dementia-Freealzinfo.org · 30 Sept 2026
2. Looking to lower your risk of Alzheimer’s? It doesn’t involve a blood testindependent.co.uk · 29 Sept 2026
3. How 3 health factors can help delay dementia for up to 13 yearsnbcnews.com · 12 Aug 2026
4. Three middle-age health rules could bring an extra 13 years without dementia, experts saynews.sky.com · 12 Aug 2026
5. Three factors in midlife can delay the onset of dementia by 13 yearsnewscientist.com · 10 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

• Early-onset Alzheimer's disease shows different warning signs from established risk factorsMedical Xpress
• Earlier Alzheimer’s Treatment Could Increase Lifetime BenefitsEMJ
• Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health dataNature

Contact & links

• Staff pagehttps://med.nyu.edu/faculty/josef-coresh
• LinkedInhttps://www.linkedin.com/in/josef-coresh-3624a635/

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.